ALLO
Price
$1.87
Change
+$0.03 (+1.63%)
Updated
Dec 20 closing price
66 days until earnings call
ANIX
Price
$2.69
Change
-$0.00 (-0.00%)
Updated
Dec 20, 04:59 PM (EDT)
10 days until earnings call
Ad is loading...

ALLO vs ANIX

Header iconALLO vs ANIX Comparison
Open Charts ALLO vs ANIXBanner chart's image
Allogene Therapeutics
Price$1.87
Change+$0.03 (+1.63%)
Volume$4.99M
CapitalizationN/A
Anixa Biosciences
Price$2.69
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
ALLO vs ANIX Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. ANIX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and ANIX is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ALLO: $1.87 vs. ANIX: $2.69)
Brand notoriety: ALLO and ANIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 198% vs. ANIX: 88%
Market capitalization -- ALLO: $392.09M vs. ANIX: $86.17M
ALLO [@Biotechnology] is valued at $392.09M. ANIX’s [@Biotechnology] market capitalization is $86.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileANIX’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • ANIX’s FA Score: 0 green, 5 red.
According to our system of comparison, ANIX is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while ANIX’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 6 bearish.
  • ANIX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ALLO and ANIX are a bad buy in the short-term.

Price Growth

ALLO (@Biotechnology) experienced а -1.06% price change this week, while ANIX (@Biotechnology) price change was -5.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

ANIX is expected to report earnings on Mar 14, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($392M) has a higher market cap than ANIX($86.2M). ANIX YTD gains are higher at: -30.670 vs. ALLO (-41.745). ANIX has higher annual earnings (EBITDA): -12.92M vs. ALLO (-256.67M). ALLO has more cash in the bank: 292M vs. ANIX (23.2M). ANIX has less debt than ALLO: ANIX (149K) vs ALLO (85.1M). ALLO has higher revenues than ANIX: ALLO (43K) vs ANIX (0).
ALLOANIXALLO / ANIX
Capitalization392M86.2M455%
EBITDA-256.67M-12.92M1,986%
Gain YTD-41.745-30.670136%
P/E RatioN/AN/A-
Revenue43K0-
Total Cash292M23.2M1,259%
Total Debt85.1M149K57,114%
FUNDAMENTALS RATINGS
ALLO vs ANIX: Fundamental Ratings
ALLO
ANIX
OUTLOOK RATING
1..100
7368
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
8564
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIX's Valuation (74) in the Computer Peripherals industry is in the same range as ALLO (97) in the Biotechnology industry. This means that ANIX’s stock grew similarly to ALLO’s over the last 12 months.

ANIX's Profit vs Risk Rating (100) in the Computer Peripherals industry is in the same range as ALLO (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to ALLO’s over the last 12 months.

ANIX's SMR Rating (97) in the Computer Peripherals industry is in the same range as ALLO (97) in the Biotechnology industry. This means that ANIX’s stock grew similarly to ALLO’s over the last 12 months.

ANIX's Price Growth Rating (64) in the Computer Peripherals industry is in the same range as ALLO (85) in the Biotechnology industry. This means that ANIX’s stock grew similarly to ALLO’s over the last 12 months.

ANIX's P/E Growth Rating (100) in the Computer Peripherals industry is in the same range as ALLO (100) in the Biotechnology industry. This means that ANIX’s stock grew similarly to ALLO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOANIX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 27 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVDA134.704.02
+3.08%
NVIDIA Corp
SLNO45.18-0.02
-0.04%
Soleno Therapeutics
RGLD133.81-0.29
-0.22%
Royal Gold
BOC14.32-0.08
-0.56%
Boston Omaha Corp
UPLD4.33-0.25
-5.46%
Upland Software

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with GERN. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
N/A
GERN - ANIX
33%
Loosely correlated
-4.64%
CDTX - ANIX
27%
Poorly correlated
+3.15%
ALLO - ANIX
26%
Poorly correlated
+1.63%
RYTM - ANIX
26%
Poorly correlated
+1.15%
DNLI - ANIX
26%
Poorly correlated
-0.19%
More